Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis

Research output: Contribution to journalArticlepeer-review

8 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences